Association between low-dose acetylsalicylic acid reinitiation and the risk of myocardial infarction or coronary heart disease death

Conclusions ASA reinitiation was not associated with a decreased risk of myocardial infarction/coronary heart disease death. This may be explained by confounding by indication/comorbidity, whereby higher-risk patients are more likely to reinitiate therapy. An additional period of ASA discontinuation among reinitiators was associated with an increased risk of myocardial infarction/coronary heart disease death.
Source: European Journal of Preventive Cardiology - Category: Cardiology Authors: Tags: Original scientific papers Source Type: research